Synthesis and beta-lactamase inhibitory activity of new 6 beta-sulfonamidopenicillanic acids. 1994

L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
Chemical Pharmaceutical Research Institute, Bulgarian Academy of Sciences, Sofia.

New 6 beta-aryl(alkyl)sulfonamidopenicillanic acids and their sulfoxides were synthesized by sulfonylation of 6 beta-aminopenicilanic acid or its beta-sulfoxide with an appropriate sulfonyl chloride. The corresponding 6 beta-sulfonamidopenicillanic acids sulfones were prepared by oxidation of the sulfoxides with potassium permanganate in aqueous medium. The obtained compounds reduced the minimum inhibitory concentrations of ampicillin against 8 reference and 7 clinically isolated strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D065093 beta-Lactamase Inhibitors Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. beta Lactamase Inhibitor,beta Lactamase Inhibitors,beta-Lactamase Inhibitor,beta Lactamase Antagonists,Antagonists, beta Lactamase,Inhibitor, beta Lactamase,Inhibitor, beta-Lactamase,Inhibitors, beta Lactamase,Inhibitors, beta-Lactamase,Lactamase Antagonists, beta,Lactamase Inhibitor, beta,Lactamase Inhibitors, beta

Related Publications

L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
December 1993, Bioorganic & medicinal chemistry,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
December 1999, Bioorganic & medicinal chemistry,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
January 1988, The Journal of antibiotics,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
January 1984, Acta poloniae pharmaceutica,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
September 1994, The Journal of antibiotics,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
January 1989, The Journal of antibiotics,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
January 1985, Chemotherapy,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
January 1983, Antimicrobial agents and chemotherapy,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
February 1992, The Journal of antibiotics,
L S Changov, and B K Vassileva-Lukanova, and A Angelova-Galabova, and A V Pavlova, and S L Spassov
April 1980, The Journal of antibiotics,
Copied contents to your clipboard!